Lifestyle factors have been well studied in relation to breast cancer prognosis overall; however, associations of lifestyle and late outcomes (>5 years after diagnosis) have been much less studied, and no studies have focused on estrogen receptor‐positive (ER+) breast cancer survivors, who may have high risk of late recurrence and mortality. We utilized a large prospective pooling study to evaluate the associations of lifestyle factors with late recurrence and all‐cause mortality among 6,295 5‐year ER+ Stage I–III breast cancer survivors. Pooled and harmonized data were available on clinical factors and lifestyle factors (pre‐ to post‐diagnosis weight change, body mass index (BMI) (kg/m2), recreational physical activity, alcohol intake and smoking history), measured on average 2.1 years after diagnosis. Updated information for weight only was available. Study heterogeneity was evaluated by the Q‐statistic. Multivariable Cox regression models were stratified by study. Adjusting for clinical factors and potential confounders, ≥10% weight gain and obesity (BMI, 30–34.99 and ≥35) were associated with increased risk of late recurrence (hazard ratios (95% confidence intervals): 1.24 (1.00–1.53), 1.40 (1.05–1.86) and 1.41 (1.02–1.93), respectively). Daily alcohol intake was associated with late recurrence, 1.28 (1.01–1.62). Physical activity was inversely associated with late all‐cause mortality (0.81 (0.71–0.93) and 0.71 (0.61–0.82) for 4.9 to <17.4 and ≥17.4 metabolic equivalent‐hr/week). A U‐shaped association was observed for late all‐cause mortality and BMI using updated weight (1.42 (1.15–1.74) and 1.40 (1.09–1.81), <21.5 and ≥35, respectively). Smoking was associated with increased risk of late outcomes. In this large prospective pooling project, modifiable lifestyle factors were associated with late outcomes among long‐term ER+ breast cancer survivors.
21 December 2011 in Breast Cancer Research and Treatment
Background: Oxidative stress may play an important role in both initiation and progression of breast cancer. We conducted the first systematic epidemiologic review to summarize the published literature on oxidative stress biomarkers and breast cancer. Materials and Methods: We implemented systematic search strategies to identify published studies of oxidative stress biomarkers and (1) risk of developing breast cancer and (2) breast cancer prognosis using the PRISMA statement guidelines. Results: We identified eleven case–control studies of oxidative stress biomarkers and breast cancer. Biomarkers utilized varied and menopausal status was a key modifying factor. Across three nested case–control studies with biomarkers measured before diagnosis, one reported increased risk of postmenopausal breast cancer in association with 8-oxodG (DNA damage biomarker), while two (one of F2-isoprostanes and one of fluorescent oxidation products) reported inverse associations for premenopausal breast cancer only. We identified eight prognostic studies. Two reported associations for lipid peroxidation and breast cancer prognosis; results for other studies were null. Conclusions: DNA damage may increase risk of breast cancer among postmenopausal women, while lipid peroxidation may be inversely associated with premenopausal breast cancer. Lipid peroxidation may be associated with survival after breast cancer diagnosis; however, results require evaluation in large, prospective cohort studies.
1 August 2012 in Cancer Epidemiology, Biomarkers & Prevention